New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 21, 2014
07:06 EDTKPTIKaryopharm announces Phase 1 trial of Selinexor
Karyopharm Therapeutics announced the initiation of its first pediatric clinical study, a Phase 1 trial of its novel, oral Selective Inhibitor of Nuclear Export, or SINE, compound Selinexor in pediatric patients. The trial will enroll up to 28 children with relapsed or refractory acute lymphoblastic leukemia, or ALL, or acute myeloblastic leukemia, or AML.
News For KPTI From The Last 14 Days
Check below for free stories on KPTI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 8, 2014
07:38 EDTKPTIKaryopharm appoints Justin Renz as CFO
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use